Ariad Pharmaceuticals Inc fka ARIA

[biotech_researcher]

Still, even for a third round treatment, if 10 out of 77 patients discontinued treatment, that would be a real negative in my book, and would not have been anywhere near the trial results. Ariad would have to respond, and rather quickly I would think.. Someone is way off here..